126 related articles for article (PubMed ID: 7197189)
1. Clinical evaluation of sequentially scheduled cisplatin and VM26 in neuroblastoma: response and toxicity.
Hayes FA; Green AA; Casper J; Cornet J; Evans WE
Cancer; 1981 Oct; 48(8):1715-8. PubMed ID: 7197189
[TBL] [Abstract][Full Text] [Related]
2. Sequential cis-platinum and VM26 in neuroblastoma: laboratory and clinical (OPEC regimen) studies.
Pritchard J; Whelan R; Hill BT
Prog Clin Biol Res; 1985; 175():545-55. PubMed ID: 4039448
[No Abstract] [Full Text] [Related]
3. [Effectiveness of cis-dichlorodiammine-platinum in the treatment of advanced neuroblastoma].
Ohnuma N; Takahashi H; Maie M; Etoh T; Tanabe M; Kuriyama Y
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2876-80. PubMed ID: 3662544
[TBL] [Abstract][Full Text] [Related]
4. Epipodophyllotoxin VM-26 in the treatment of childhood neuroblastoma.
Rivera G; Green A; Hayes A; Avery T; Pratt C
Cancer Treat Rep; 1977 Oct; 61(7):1243-8. PubMed ID: 589594
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide/doxorubicin vs. cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: a Pediatric Oncology Group Randomized Phase II study.
McWilliams NB; Hayes FA; Green AA; Smith EI; Nitschke R; Altshuler GA; Shuster JJ; Castleberry RP; Vietti TJ
Med Pediatr Oncol; 1995 Mar; 24(3):176-80. PubMed ID: 7838039
[TBL] [Abstract][Full Text] [Related]
6. [Hypersensitivity to VM-26].
Köster B; Ritter J; Bode U
Klin Padiatr; 1984; 196(3):178-80. PubMed ID: 6540829
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of advanced neuroblastoma with regimens containing cis-dichlorodiammineplatinum--effect and toxicity].
Bessho F; Mizutani S; Kinumaki H; Kaku H; Nakamura K; Inaba T; Tsuchida Y; Yokota S; Kobayashi N
Gan To Kagaku Ryoho; 1984 May; 11(5):1116-21. PubMed ID: 6539099
[TBL] [Abstract][Full Text] [Related]
8. Carboplatin activity in cisplatin treated neuroblastoma.
Lewis IJ; Stevens MC; Pearson AD; Pinkerton CR; Barnes JM
Prog Clin Biol Res; 1991; 366():553-9. PubMed ID: 2068173
[No Abstract] [Full Text] [Related]
9. Pediatric cancer chemotherapy: an updated review. I. Cis-Diammine--dichloroplatinum II (cisplatin), VM-26 (teniposide), VP-16 (etoposide), mitomycin C.
Gutierrez ML; Crooke ST
Cancer Treat Rev; 1979 Sep; 6(3):153-64. PubMed ID: 394834
[No Abstract] [Full Text] [Related]
10. [Chemotherapy with higher or lower dose of teniposide combined with cisplatin and pingyangmycin for oral squamous cell carcinoma].
Chen WT; Guo W; Xu Q; Pan HY; Ye DX; Qiu WL
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 May; 39(3):218-20. PubMed ID: 15196390
[TBL] [Abstract][Full Text] [Related]
11. Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.
Shafford EA; Rogers DW; Pritchard J
J Clin Oncol; 1984 Jul; 2(7):742-7. PubMed ID: 6539811
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial.
Rodman JH; Abromowitch M; Sinkule JA; Hayes FA; Rivera GK; Evans WE
J Clin Oncol; 1987 Jul; 5(7):1007-14. PubMed ID: 3598607
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study Group.
Bleyer WA; Krivit W; Chard RL; Hammond D
Cancer Treat Rep; 1979 Jun; 63(6):977-81. PubMed ID: 380803
[TBL] [Abstract][Full Text] [Related]
14. Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy.
Giaccone G; Donadio M; Bonardi G; Testore F; Calciati A
J Clin Oncol; 1988 Aug; 6(8):1264-70. PubMed ID: 2842464
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma.
Cheung NV; Heller G
J Clin Oncol; 1991 Jun; 9(6):1050-8. PubMed ID: 2033419
[TBL] [Abstract][Full Text] [Related]
16. Sequential cisplatin/VM-26 and vincristine/cyclophosphamide/doxorubicin in metastatic neuroblastoma: an effective alternating non-cross-resistant regimen?
Bernard JL; Philip T; Zucker JM; Frappaz D; Robert A; Margueritte G; Boilletot A; Philippe N; Lutz P; Roche H
J Clin Oncol; 1987 Dec; 5(12):1952-9. PubMed ID: 3681378
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of high-dose cisplatin and VP-16 in neuroblastoma: a report from the Société Française d'Oncologie Pédiatrique.
Philip T; Ghalie R; Pinkerton R; Zucker JM; Bernard JL; Leverger G; Hartmann O
J Clin Oncol; 1987 Jun; 5(6):941-50. PubMed ID: 3585448
[TBL] [Abstract][Full Text] [Related]
18. Allergic reactions to teniposide in patients with neuroblastoma and lymphoid malignancies.
Hayes FA; Abromowitch M; Green AA
Cancer Treat Rep; 1985 Apr; 69(4):439-41. PubMed ID: 3857970
[TBL] [Abstract][Full Text] [Related]
19. Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation.
McCowage GB; Vowels MR; Shaw PJ; Lockwood L; Mameghan H
J Clin Oncol; 1995 Nov; 13(11):2789-95. PubMed ID: 7595740
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
